Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-1947
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Low-dose axitinib rechallenge with positive outcomes in a patient with metastatic renal cell carcinoma refractory to interferon α, sunitinib, axitinib, and nivolumab therapies: a case report ; volume:13 ; number:1 ; day:22 ; month:4 ; year:2019 ; pages:1-5 ; date:12.2019
Journal of medical case reports ; 13, Heft 1 (22.4.2019), 1-5, 12.2019
- Creator
-
Murata, Masaki
Ikeda, Yohei
Hasegawa, Go
Nakagawa, Yuki
Nishiyama, Tsutomu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13256-019-2041-8
- URN
-
urn:nbn:de:101:1-2019051612231015515731
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Murata, Masaki
- Ikeda, Yohei
- Hasegawa, Go
- Nakagawa, Yuki
- Nishiyama, Tsutomu
- SpringerLink (Online service)
Other Objects (12)
Low-dose nivolumab in advanced hepatocellular carcinoma
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
Clinical and Preclinical Experience with Gefitinib and Sunitinib
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
Sunitinib-Sorafenib- versus Sunitinib-Everolimus-Sequenztherapie beim Nierenzellkarzinom
Early onset recall pneumonitis during targeted therapy with sunitinib
Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis
Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
Pneumatosis cystoides intestinalis associated with sunitinib and a literature review
Vesicocutaneous fistula formation during treatment with sunitinib malate: Case report
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Metastatic collecting duct carcinoma of the kidney treated with sunitinib
Low-dose nivolumab in advanced hepatocellular carcinoma
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
Clinical and Preclinical Experience with Gefitinib and Sunitinib
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
Sunitinib-Sorafenib- versus Sunitinib-Everolimus-Sequenztherapie beim Nierenzellkarzinom
Early onset recall pneumonitis during targeted therapy with sunitinib
Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis
Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
Pneumatosis cystoides intestinalis associated with sunitinib and a literature review
Vesicocutaneous fistula formation during treatment with sunitinib malate: Case report
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
Metastatic collecting duct carcinoma of the kidney treated with sunitinib
Low-dose nivolumab in advanced hepatocellular carcinoma
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer
Clinical and Preclinical Experience with Gefitinib and Sunitinib
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
Sunitinib-Sorafenib- versus Sunitinib-Everolimus-Sequenztherapie beim Nierenzellkarzinom
Early onset recall pneumonitis during targeted therapy with sunitinib
Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis
Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
Pneumatosis cystoides intestinalis associated with sunitinib and a literature review
Vesicocutaneous fistula formation during treatment with sunitinib malate: Case report
Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids